+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.

Slides:



Advertisements
Similar presentations
Development Cycle of Medical Devices: A Path of Opportunities for Information Professionals Donna Gay Pharma & Health Tech Div, SLA 2007 Spring Meeting.
Advertisements

Investigational Device Exemption (IDE) Overview for IRBs
Regulatory Pathway for Platform Technologies
Entering the US Market: Medical Devices
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Overview of FDA Device Regulations
Regulation of Medical Devices Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation.
"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
Humanitarian Device Exemptions (HDE) 101 Elizabeth Hillebrenner, MSE Biomedical Engineer IDE and HDE Program Staff Center for Devices and Radiological.
Strengthening the Medical Device Clinical Trial Enterprise
510k Submission Overview Myraqa, Inc. August 22, 2012.
Medical Device Submissions
University of Medicine and Dentistry of New Jersey John L. Ricci, Ph.D., Department of Orthopaedics History and Scope of Biomaterials J. L. Ricci, Ph.D.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Special Topics in IND Regulation
Medical Devices Approval Process
Donna M. Liewer FCLB Executive Director Understanding the FDA: Key Considerations for Regulatory Agencies.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Radiological Devices Advisory Committee Meeting November 18, 2009 John A. DeLucia iCAD, Inc.
Pharm 411 Medical Devices Overview of Device Regulations
Team SaltronTM October 25th, 2010
Basic Principles of FDA Medical Device Regulation and How FDA Might Have Handled the Recent PIP Crisis British Institute of International and Comparative.
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Device Research Presented by Marian Serge, R.N.. Goals Identify devices Recognize difference between significant risk (SR) and non- significant risk (NSR)
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.
Medical Devices IRB Determination IRB Member Continuing Education.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
OIVD Workshop Premarket Notification (510(k)) April 22, 2003 Parklawn Building Rockville, MD Presented by Marjorie Shulman Premarket Notification Staff.
FDA Focus On Consumer Protection
UNCLASSIFIED10/12/ :41 AM Slide 1 Division of Regulated Activities and Compliance.
510(k) Process: Best Practices in Changing Times… MassMEDIC Massachusetts Medical Society, Waltham, MA April 1, :00 AM - 10:30 AM.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
Food and Drug Administration Kevin Bedal, Lisa Carlin, Matt Carroll, Erin Nichols October 24 th, 2011.
Medicare Submission for Pre-Approval in Clinical Research Ronda Sharp, R.N., B.S.N., C.C.R.C. Clinical Research Facilitator Methodist Research Institute.
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
FDLI Introduction to Medical Device Law and Regulation Other Postmarket Controls Philip Katz (202) October 29, 2002 Washington,
Food and Drug Administration Michael Jordan and Jeff Beegle October 23 nd, 2013.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food.
The Food and Drug Administration Allison Kotchman Victoria Gilbride.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
Investigational Devices and Humanitarian Use Devices June 2007.
REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR
AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.
Radiology Advisory Panel Meeting Radiology Advisory Panel Meeting Computer-Assisted Detection (CADe) Devices Joyce M. Whang Deputy Division Director Radiological.
Moj Eram, PhD Senior Consultant ARC Experts, LLC 6 April, 2016
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
Use of Postmarket Data to Support Premarket Approvals
GCP AND MEDICAL DEVICES
The Food and Drug Administration
What Are the FDA Requirements for Submitting an IDE?
Division of Cardiovascular Devices
U.S. FDA Center for Devices and Radiological Health Update
Premarket Notification 510(k) process
FDA’s IDE Decisions and Communications
How to Put Together an IDE Application
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
FDA-CDRH in the Next Decade A Vision for Change
Implantable Medical Devices: Accelerating Standards Development to Streamline Regulation Joshua Price | August 2,
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Opening an IND: Investigator Perspective
Presentation transcript:

+ Medical Devices Approval Process

+ Objectives Define a medical device Be familiar with the classification system for medical devices Understand the difference between medical device approval and medication approval Define 510(k) Premarket Notification Explain the role of the Food and Drug Administration (FDA) in the medical device approval and review process in the United States

+ Medical Devices The Food, Drug and Cosmetic Act of 1938 defined devices as “Instruments, apparatus, and contrivances, including their components, parts and accessories, intended for use in the diagnosis, cure mitigation, treatment or prevention of disease in man or other animals; or to affect the structure or any function of the body of man or other animals“

+ FDA Role FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. In addition, CDRH regulates radiation- emitting electronic products (medical and non-medical) such as lasers, x-ray systems, ultrasound equipment, microwave ovens and color televisions.

+ Classification of Medical Devices Medical devices are classified into Class I, II, and III Regulatory control increases from Class I to Class III. The device classification regulation defines the regulatory requirements for a general device type. Most Class I devices are exempt from Premarket Notification 510(k); most Class II devices require Premarket Notification 510(k); and most Class III devices require Premarket Approval.

+ Class I Devices: General Controls Class I: Devices for which general controls are sufficient to provide reasonable assurance of safety and effectiveness General Controls are: – Adulteration and misbranding provisions – Registration and listing – Premarket notification (510(k))* (for a limited number of Class I devices) – Records and reports – Good Manufacturing Practices (unless exempt) Examples: scalpels, tongue depressors * 510 (k) submission is to demonstrate substantial equivalence to a device that is already legally marketed.

+ Class II Devices: General Controls and Special Controls Class II: Devices for which general controls alone are insufficient to establish safety and effectiveness. Must meet general controls as well as special controls Special Controls are: Performance standards – Postmarket surveillance – Patient registries, guidelines recommendations, and “other appropriate actions” Examples: Laser for general surgery, diagnostic ultrasound, many intravascular devices

+ Class III Devices: General Controls and Premarket Approval Class III: Devices for which general and special controls alone are not sufficient to establish safety and efficacy and devices that are: (i) used in supporting or sustaining human life or (ii) are for a use which is of substantial importance in preventing impairment of human health or (iii) present a potential unreasonable risk of illness or injury Examples: artificial hearts, laser for ophthalmic surgery, many spinal implants

+ Premarket Approval Class III devices are subject to premarket approval (PMA) Could be Class III because of high risk or because of lack of predicate device Once a device is in Class III for a certain indication, all devices of that kind must have a PMA

+ Investigational Device Exemption (IDE) Investigational Device – Is still in the developmental stage – Is the object of a clinical investigation to determine safety & effectiveness – Is not considered to be in commercial distribution Investigational Use Clinical evaluation of a legally marketed device for a new intended use

+ Investigational Device Exemption (IDE) Sponsor submits IDE to FDA FDA approves or disapproves within 30 days Sponsor obtains IRB approval After both FDA and IRB approve, sponsor can begin investigation For non-significant risk IDEs sponsor presents protocol to IRB and a statement why investigation does not pose significant risk If IRB approves, investigation can begin

+ Premarket Notification (510(k)) 510(k) is a premarket submission to the FDA that demonstrates that the device is substantially equivalent to a legally marketed device What is substantially equivalent? The device is: Has the same use Has the same technological characteristics Does not require same clinical research as required of medications

+ Clinical Data Requirements 90% or more of 510(k) notices do not require clinical data Clearance based on bench testing and/or animal testing, identified through appropriate risk analysis All PMAs generally require clinical data Foreign data may be used but is rarely the sole basis for a PMA

+ Medical Device User Fees User Fees for Device submissions 510(k): $3,833 standard fee PMA, PDP, PMR (reprocessed), BLAs for devices: $259,600 standard fee Reduced fees for small businesses

+ Resources dance/default.htm